About
Cypre develops 3D human-derived tumor organoid models using proprietary hydrogel technology that integrate tumor, stromal, and immune components to improve the predictivity of cancer drug development and translational research.
Explore Cypre's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.